• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物肽激活脑胶质瘤中的肿瘤浸润淋巴细胞。

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma.

机构信息

Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.

Cellerys AG, Schlieren, Switzerland.

出版信息

Nature. 2023 May;617(7962):807-817. doi: 10.1038/s41586-023-06081-w. Epub 2023 May 17.

DOI:10.1038/s41586-023-06081-w
PMID:37198490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10208956/
Abstract

Microbial organisms have key roles in numerous physiological processes in the human body and have recently been shown to modify the response to immune checkpoint inhibitors. Here we aim to address the role of microbial organisms and their potential role in immune reactivity against glioblastoma. We demonstrate that HLA molecules of both glioblastoma tissues and tumour cell lines present bacteria-specific peptides. This finding prompted us to examine whether tumour-infiltrating lymphocytes (TILs) recognize tumour-derived bacterial peptides. Bacterial peptides eluted from HLA class II molecules are recognized by TILs, albeit very weakly. Using an unbiased antigen discovery approach to probe the specificity of a TIL CD4 T cell clone, we show that it recognizes a broad spectrum of peptides from pathogenic bacteria, commensal gut microbiota and also glioblastoma-related tumour antigens. These peptides were also strongly stimulatory for bulk TILs and peripheral blood memory cells, which then respond to tumour-derived target peptides. Our data hint at how bacterial pathogens and bacterial gut microbiota can be involved in specific immune recognition of tumour antigens. The unbiased identification of microbial target antigens for TILs holds promise for future personalized tumour vaccination approaches.

摘要

微生物在人体的许多生理过程中起着关键作用,最近的研究表明它们可以改变机体对免疫检查点抑制剂的反应。在这里,我们旨在探讨微生物及其在胶质母细胞瘤免疫反应中的潜在作用。我们发现胶质母细胞瘤组织和肿瘤细胞系的 HLA 分子呈递细菌特异性肽。这一发现促使我们研究肿瘤浸润淋巴细胞(TIL)是否识别肿瘤来源的细菌肽。从 HLA Ⅱ类分子洗脱的细菌肽可被 TIL 识别,尽管识别非常弱。我们使用一种无偏见的抗原发现方法来探测 TIL CD4 T 细胞克隆的特异性,结果表明它识别广泛存在于致病菌、肠道共生菌以及与胶质母细胞瘤相关的肿瘤抗原中的肽段。这些肽段也强烈刺激了 TIL 群体和外周血记忆细胞,使其对肿瘤来源的靶肽产生反应。我们的数据提示了细菌病原体和肠道共生菌如何参与肿瘤抗原的特异性免疫识别。为 TIL 鉴定无偏微生物靶抗原的方法为未来的个性化肿瘤疫苗接种方法提供了希望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/bb7b889d03e7/41586_2023_6081_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/1c089c755922/41586_2023_6081_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/b332ca1fac52/41586_2023_6081_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/9faab2a24c8b/41586_2023_6081_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/25b05eeb4745/41586_2023_6081_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/1f72d783a138/41586_2023_6081_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/2212667628f5/41586_2023_6081_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/b6388369057c/41586_2023_6081_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/e3798145498e/41586_2023_6081_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/45a4d3f89e93/41586_2023_6081_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/746ccc7c1167/41586_2023_6081_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/2c8aa0455ab6/41586_2023_6081_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/9c0360c50706/41586_2023_6081_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/4836c4a154e6/41586_2023_6081_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/bb7b889d03e7/41586_2023_6081_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/1c089c755922/41586_2023_6081_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/b332ca1fac52/41586_2023_6081_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/9faab2a24c8b/41586_2023_6081_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/25b05eeb4745/41586_2023_6081_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/1f72d783a138/41586_2023_6081_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/2212667628f5/41586_2023_6081_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/b6388369057c/41586_2023_6081_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/e3798145498e/41586_2023_6081_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/45a4d3f89e93/41586_2023_6081_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/746ccc7c1167/41586_2023_6081_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/2c8aa0455ab6/41586_2023_6081_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/9c0360c50706/41586_2023_6081_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/4836c4a154e6/41586_2023_6081_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7495/10208956/bb7b889d03e7/41586_2023_6081_Fig14_ESM.jpg

相似文献

1
Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma.微生物肽激活脑胶质瘤中的肿瘤浸润淋巴细胞。
Nature. 2023 May;617(7962):807-817. doi: 10.1038/s41586-023-06081-w. Epub 2023 May 17.
2
Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.多种HLA II类限制性黑素细胞分化抗原可被一名黑色素瘤患者的肿瘤浸润淋巴细胞识别。
J Immunol. 2002 Nov 15;169(10):6036-47. doi: 10.4049/jimmunol.169.10.6036.
3
Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.肿瘤特异性CTL反应需要四种不同细胞类型的相互作用以及对MHC I类和II类限制性肿瘤抗原的识别。
Immunol Cell Biol. 1993 Aug;71 ( Pt 4):311-26. doi: 10.1038/icb.1993.36.
4
Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.黑色素瘤特异性CD4 + T淋巴细胞可识别由爱泼斯坦-巴尔病毒转化的B细胞加工并呈递的人类黑色素瘤抗原。
Int J Cancer. 1994 Jul 1;58(1):69-79. doi: 10.1002/ijc.2910580113.
5
Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients.黑素细胞刺激素 1 受体衍生肽可被黑素瘤患者的细胞毒性 T 淋巴细胞有效识别。
Immunobiology. 2014 Mar;219(3):189-97. doi: 10.1016/j.imbio.2013.10.002. Epub 2013 Oct 12.
6
Identification of bacteria-derived HLA-bound peptides in melanoma.鉴定黑色素瘤中细菌衍生的 HLA 结合肽。
Nature. 2021 Apr;592(7852):138-143. doi: 10.1038/s41586-021-03368-8. Epub 2021 Mar 17.
7
Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.人肿瘤浸润淋巴细胞识别的黑色素瘤肿瘤相关抗原的共同表达:通过人类淋巴细胞抗原限制进行分析
J Immunother (1991). 1991 Jun;10(3):153-64.
8
New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models.新一代基于 DNA 的免疫疗法可诱导强烈的免疫反应,并提高不同肿瘤模型的生存率。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-001243.
9
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma.黑色素瘤肿瘤浸润 T 淋巴细胞的共享抗原表位及其同源 TCR 的景观图谱。
Elife. 2020 Apr 21;9:e53244. doi: 10.7554/eLife.53244.
10
A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses.一种人类黑色素瘤细胞系,可被I类和II类HLA限制性T细胞识别,能够引发初次和二次免疫反应。
Scand J Immunol. 1995 Apr;41(4):357-64. doi: 10.1111/j.1365-3083.1995.tb03579.x.

引用本文的文献

1
Microbiota-mediated mechanisms of mucosal immunity across the lifespan.微生物群介导的全生命周期黏膜免疫机制。
Nat Immunol. 2025 Sep 16. doi: 10.1038/s41590-025-02281-w.
2
Immunologic specificity in glioblastoma: Antigen discovery and translational implications.胶质母细胞瘤中的免疫特异性:抗原发现及转化意义
Neurooncol Adv. 2025 Sep 9;7(Suppl 4):iv41-iv70. doi: 10.1093/noajnl/vdaf028. eCollection 2025 Sep.
3
Deciphering the Potential Causal and Prognostic Relationships Between Gut Microbiota and Brain Tumors: Insights from Genetics Analysis and Machine Learning.

本文引用的文献

1
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.肿瘤内微生物群对癌症空间和细胞异质性的影响。
Nature. 2022 Nov;611(7937):810-817. doi: 10.1038/s41586-022-05435-0. Epub 2022 Nov 16.
2
Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides.基于单细胞 RNA 测序的蛋白质基因组学鉴定出编码 HLA-I 呈递肽的神经胶质瘤特异性转座元件。
Cell Rep. 2022 Jun 7;39(10):110916. doi: 10.1016/j.celrep.2022.110916.
3
Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer.
解读肠道微生物群与脑肿瘤之间潜在的因果关系和预后关系:来自遗传学分析和机器学习的见解
Exploration (Beijing). 2025 May 1;5(4):e20240087. doi: 10.1002/EXP.20240087. eCollection 2025 Aug.
4
The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy.肿瘤内微生物群在结直肠癌免疫治疗中的作用与挑战
Front Pharmacol. 2025 Aug 7;16:1634703. doi: 10.3389/fphar.2025.1634703. eCollection 2025.
5
Oncolytic Therapies for Glioblastoma: Advances, Challenges, and Future Perspectives.胶质母细胞瘤的溶瘤疗法:进展、挑战与未来展望
Cancers (Basel). 2025 Aug 1;17(15):2550. doi: 10.3390/cancers17152550.
6
Exploiting TCR Repertoire Analysis to Select Therapeutic TCRs for Cancer Immunotherapy.利用T细胞受体库分析来选择用于癌症免疫治疗的治疗性T细胞受体
Cells. 2025 Aug 7;14(15):1223. doi: 10.3390/cells14151223.
7
Research and Clinical Progress of Therapeutic Tumor Vaccines.治疗性肿瘤疫苗的研究与临床进展
Vaccines (Basel). 2025 Jun 23;13(7):672. doi: 10.3390/vaccines13070672.
8
Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines.治疗性癌症疫苗靶向递送载体的战略进展
Int J Mol Sci. 2025 Jul 17;26(14):6879. doi: 10.3390/ijms26146879.
9
Gut microbiota shapes cancer immunotherapy responses.肠道微生物群塑造癌症免疫治疗反应。
NPJ Biofilms Microbiomes. 2025 Jul 25;11(1):143. doi: 10.1038/s41522-025-00786-8.
10
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease.在患有结直肠癌或炎症性肠病的患者中,血液传播的免疫细胞携带着微生物的低生物量DNA残余物。
Gut Microbes. 2025 Dec;17(1):2530157. doi: 10.1080/19490976.2025.2530157. Epub 2025 Jul 20.
肿瘤驻留细胞内微生物群促进乳腺癌的转移定植。
Cell. 2022 Apr 14;185(8):1356-1372.e26. doi: 10.1016/j.cell.2022.02.027. Epub 2022 Apr 7.
4
The lung microbiome regulates brain autoimmunity.肺部微生物组调节大脑自身免疫。
Nature. 2022 Mar;603(7899):138-144. doi: 10.1038/s41586-022-04427-4. Epub 2022 Feb 23.
5
Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.共生细菌和真菌可差异化调节肿瘤对放射疗法的反应。
Cancer Cell. 2021 Sep 13;39(9):1202-1213.e6. doi: 10.1016/j.ccell.2021.07.002. Epub 2021 Jul 29.
6
Pitfalls in HLA Ligandomics-How to Catch a Li(e)gand.HLA 配体组学的陷阱——如何捕捉配体。
Mol Cell Proteomics. 2021;20:100110. doi: 10.1016/j.mcpro.2021.100110. Epub 2021 Jun 12.
7
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.HLA 配体图谱:改善基于 T 细胞的癌症免疫疗法的 HLA 呈递肽的良性参考。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-002071.
8
A vaccine targeting mutant IDH1 in newly diagnosed glioma.针对新诊断的神经胶质瘤中突变 IDH1 的疫苗。
Nature. 2021 Apr;592(7854):463-468. doi: 10.1038/s41586-021-03363-z. Epub 2021 Mar 24.
9
Identification of bacteria-derived HLA-bound peptides in melanoma.鉴定黑色素瘤中细菌衍生的 HLA 结合肽。
Nature. 2021 Apr;592(7852):138-143. doi: 10.1038/s41586-021-03368-8. Epub 2021 Mar 17.
10
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.在人类非小细胞肺癌中进行共享 T 细胞特异性的全局分析,可实现 HLA 推断和抗原发现。
Immunity. 2021 Mar 9;54(3):586-602.e8. doi: 10.1016/j.immuni.2021.02.014.